This two day conference will provide insight and discussion on PD-1, IDO blockade, inflammatory leverage, and leveraging standards of care.
Topics
Speakers and discussions will cover a range of topics including:
PD-1 and checkpoint response profiling
IDO blockade
Myeloid leverage
Immunometabolic blockade
Inflammatory leverage
Leveraging standards of care including immunoradiotherapy and immunochemotherapy
Immunometabolic adjuvants for cancer immunotherapy to be held in Charles Commons Building- Johns Hopkins, Estados Unidos between 26 março 2018 and 27 março 2018. It is organised by Abcam. It covers specific areas of Biologia e ciências da vida such as Immunotherapy. Visit the website of the conference for more detailed information or contact the organizer for specific questions.
Add to calendar2018-03-262018-03-27Europe/LondonImmunometabolic adjuvants for cancer immunotherapyhttps://www.sciencedz.net/pt/conference/34895-immunometabolic-adjuvants-for-cancer-immunotherapyCharles Commons Building- Johns Hopkins - Estados UnidosAbcam
Disclaimer : Temos como objectivo proporcionar informações precisas e confiáveis sobre os próximos eventos, mas não podemos aceitar a responsabilidade para o texto de anúncios ou boa-fé dos organizadores do evento. Por favor, não hesite em contactar-nos se você observar informações incorretas ou enganosas e vamos tentar corrigi-lo.We are not involved in the organization of any of the events listed and we do not handle registration payments on behalf of the organizers.
Subscribe Now
Subscribe to receive conference alerts and news.
Share this event
Embed this event in your webpage
Copy the text below and past it in your html code: